Codomax Inc.

Codomax develops the Epi-MAX platform, an omics-driven cell engineering technology that optimizes the production of difficult-to-express recombinant proteins by addressing cellular stress responses during biomanufacturing. The company creates custom engineered strains for customers to enable scalable, high-yield protein production for therapeutics and cellular agriculture applications.